Cargando…

Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA

As a gene therapy strategy, RNA interference (RNAi) offers tremendous tumor therapy potential. However, its therapeutic efficacy is restricted by its inferior ability for targeted delivery and cellular uptake of small interfering RNA (siRNA). This study sought to develop a dual-ligand nanoparticle (...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Qi Chang, Jiang, Shuai, Wu, Yu Zhe, Shang, Dan, Zhang, Yong, Hu, Shao Bo, Cheng, Xiang, Zhang, Chen, Sun, Ping, Gao, Yang, Song, Zi Fang, Li, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297947/
https://www.ncbi.nlm.nih.gov/pubmed/32587849
http://dx.doi.org/10.3389/fbioe.2020.00512
_version_ 1783547110995525632
author Zheng, Qi Chang
Jiang, Shuai
Wu, Yu Zhe
Shang, Dan
Zhang, Yong
Hu, Shao Bo
Cheng, Xiang
Zhang, Chen
Sun, Ping
Gao, Yang
Song, Zi Fang
Li, Min
author_facet Zheng, Qi Chang
Jiang, Shuai
Wu, Yu Zhe
Shang, Dan
Zhang, Yong
Hu, Shao Bo
Cheng, Xiang
Zhang, Chen
Sun, Ping
Gao, Yang
Song, Zi Fang
Li, Min
author_sort Zheng, Qi Chang
collection PubMed
description As a gene therapy strategy, RNA interference (RNAi) offers tremendous tumor therapy potential. However, its therapeutic efficacy is restricted by its inferior ability for targeted delivery and cellular uptake of small interfering RNA (siRNA). This study sought to develop a dual-ligand nanoparticle (NP) system loaded with siRNA to promote targeted delivery and therapeutic efficacy. We synthesized a dual receptor-targeted chitosan nanosystem (GCGA), whose target function was controlled by the ligands of galactose of lactobionic acid (LA) and glycyrrhetinic acid (GA). By loading siPAK1, an siRNA targeting P21-activated kinase 1 (PAK1), a molecular-targeted therapeutic dual-ligand NP (GCGA–siPAK1) was established. We investigated the synergistic effect of these two targeting units in hepatocellular carcinoma (HCC). In particular, GCGA–siPAK1 enhanced the NP targeting ability and promoted siPAK1 cell uptake. Subsequently, dramatic decreases in cell proliferation, invasion, and migration, with an apparent increase in cell apoptosis, were observed in treated cells. Furthermore, this dual-ligand NP gene delivery system demonstrated significant anti-tumor effects in tumor-bearing mice. Finally, we illuminated the molecular mechanism, whereby GCGA–siPAK1 promotes endogenous cell apoptosis through the PAK1/MEK/ERK pathway. Thus, the dual-target property effectively promotes the HCC therapeutic effect and provides a promising gene therapy strategy for clinical applications.
format Online
Article
Text
id pubmed-7297947
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72979472020-06-24 Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA Zheng, Qi Chang Jiang, Shuai Wu, Yu Zhe Shang, Dan Zhang, Yong Hu, Shao Bo Cheng, Xiang Zhang, Chen Sun, Ping Gao, Yang Song, Zi Fang Li, Min Front Bioeng Biotechnol Bioengineering and Biotechnology As a gene therapy strategy, RNA interference (RNAi) offers tremendous tumor therapy potential. However, its therapeutic efficacy is restricted by its inferior ability for targeted delivery and cellular uptake of small interfering RNA (siRNA). This study sought to develop a dual-ligand nanoparticle (NP) system loaded with siRNA to promote targeted delivery and therapeutic efficacy. We synthesized a dual receptor-targeted chitosan nanosystem (GCGA), whose target function was controlled by the ligands of galactose of lactobionic acid (LA) and glycyrrhetinic acid (GA). By loading siPAK1, an siRNA targeting P21-activated kinase 1 (PAK1), a molecular-targeted therapeutic dual-ligand NP (GCGA–siPAK1) was established. We investigated the synergistic effect of these two targeting units in hepatocellular carcinoma (HCC). In particular, GCGA–siPAK1 enhanced the NP targeting ability and promoted siPAK1 cell uptake. Subsequently, dramatic decreases in cell proliferation, invasion, and migration, with an apparent increase in cell apoptosis, were observed in treated cells. Furthermore, this dual-ligand NP gene delivery system demonstrated significant anti-tumor effects in tumor-bearing mice. Finally, we illuminated the molecular mechanism, whereby GCGA–siPAK1 promotes endogenous cell apoptosis through the PAK1/MEK/ERK pathway. Thus, the dual-target property effectively promotes the HCC therapeutic effect and provides a promising gene therapy strategy for clinical applications. Frontiers Media S.A. 2020-06-10 /pmc/articles/PMC7297947/ /pubmed/32587849 http://dx.doi.org/10.3389/fbioe.2020.00512 Text en Copyright © 2020 Zheng, Jiang, Wu, Shang, Zhang, Hu, Cheng, Zhang, Sun, Gao, Song and Li. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Zheng, Qi Chang
Jiang, Shuai
Wu, Yu Zhe
Shang, Dan
Zhang, Yong
Hu, Shao Bo
Cheng, Xiang
Zhang, Chen
Sun, Ping
Gao, Yang
Song, Zi Fang
Li, Min
Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
title Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
title_full Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
title_fullStr Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
title_full_unstemmed Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
title_short Dual-Targeting Nanoparticle-Mediated Gene Therapy Strategy for Hepatocellular Carcinoma by Delivering Small Interfering RNA
title_sort dual-targeting nanoparticle-mediated gene therapy strategy for hepatocellular carcinoma by delivering small interfering rna
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297947/
https://www.ncbi.nlm.nih.gov/pubmed/32587849
http://dx.doi.org/10.3389/fbioe.2020.00512
work_keys_str_mv AT zhengqichang dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT jiangshuai dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT wuyuzhe dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT shangdan dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT zhangyong dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT hushaobo dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT chengxiang dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT zhangchen dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT sunping dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT gaoyang dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT songzifang dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna
AT limin dualtargetingnanoparticlemediatedgenetherapystrategyforhepatocellularcarcinomabydeliveringsmallinterferingrna